logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > Cefpirome Sulfate CAS 98753-19-6

Cefpirome Sulfate CAS 98753-19-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 98753-19-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
CAS NO::
98753-19-6
Appearance::
White Or Off White Crystalline Powder
Molecular Formula::
C22H24N6O9S3
Molecular Weight::
612.65600
EINECS NO::
685-392-7
MDL NO::
MFCD01688770
CAS NO::
98753-19-6
Appearance::
White Or Off White Crystalline Powder
Molecular Formula::
C22H24N6O9S3
Molecular Weight::
612.65600
EINECS NO::
685-392-7
MDL NO::
MFCD01688770
Cefpirome Sulfate CAS 98753-19-6

Product Description:

Product Name: Cefpirome sulfate CAS NO: 98753-19-6


Synonyms:

1-[[(6r,7r)-7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-dihydro-5h-cyclopenta[b]pyridinium sulfate;

(6r-rboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-;


Chemical & Physical Properties:

Appearance: White or off white crystalline powder

Assay :≥99.00%

Melting Point: 198-202℃

Storage Condition: Store at 0-5℃

Solubility: Soluble in DMSO


Fourth generation cephalosporin antibiotic. Cefpirome sulfate is a new injectable cephalosporin indicated for the treatment of severe urinary and respiratory tract infections, including septicemia and nosocomial infections. Cefpirome sulfate is reported to be the first true fourth-generation cephalosporin due to its similar activities to third-generation antibiotics against Gram-positive bacteria and to first-generation antibiotics against Gram-negative bacteria. Its efficacy against P.aeruginosa is comparable to ceftazidime. The broad spectrum of activity includes Klebsiella, methicillin-sensitive staphylococci, penicillin-resistant pneumococci, E.coli which generates extended-spectrum beta-lactamases and multi-resistant organisms such as Citrobacter, Enterobacter and Serratia.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.